Main Story
-
Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location
VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) — Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has now received its Radioactive Materials License (RML) from the State of Florida for its flagship NovaScan Neuroimaging Clinics™ location (“NovaScan” or…
Products
-
AccuSure AS9 Fully Automatic Digital Blood Pressure Monitor With Large Display
Original price was: ₹1,733.00.₹998.00Current price is: ₹998.00. -
AGEasy Max Group Fully Automatic One Touch Digital Blood Pressure Monitoring Device
Original price was: ₹1,405.00.₹949.00Current price is: ₹949.00. -
Automatic Digital Blood Pressure Monitor for Upper Arm, Large LCD Display
Original price was: ₹2,399.00.₹448.00Current price is: ₹448.00. -
Beurer German Engineering P0 13 Kid’s Pulse Oximeter I Fingertip Home Pulse Oximeter
Original price was: ₹2,745.00.₹1,538.00Current price is: ₹1,538.00. -
BPL Medical Technologies Bluetooth Enabled Arm Type Blood Pressure Monitor
Original price was: ₹6,563.00.₹5,199.00Current price is: ₹5,199.00.
Automobile
Tech
Entertainment
-
Timezone and Play 'N' Learn Unveil the Ultimate Fun Destination for All Ages at Pacific Mall, Delhi
The refreshed destination brings together immersive play, new age interactive experiences, celebrations, dining and family-friendly entertainment for all ages under one roof New Delhi, Delhi, India Timezone and Play ‘N’ Learn have relaunched their entertainment spaces together at Pacific Mall, Delhi, unveiling a refreshed line-up of experiences for families, friends and guests across age groups.…
Health
-
Grey Matters Achieves Final Major Milestone; Receives Radioactive Materials License from State of Florida for its Flagship NovaScan Neuroimaging Clinics™ Location
VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) — Grey Matters Health Inc. (the “Company” or “Grey Matters”) (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is pleased to announce that it has now received its Radioactive Materials License (RML) from the State of Florida for its flagship NovaScan Neuroimaging Clinics™ location (“NovaScan” or…
-
Dubai Police Initiatives Drive $176.4 Million in Social Value and Gains in Safety, Wellbeing and the Economy, Study Reveals
DUBAI, UAE, Aug. 19, 2026 /PRNewswire/ — A study has estimated the Social Return on Investment (SROI) of 80 Dubai Police community initiatives at AED 647.9 million ($176.4 million), reflecting the wider social, economic and security value created for 3.8 million beneficiaries between 2017 and 2026. Conducted by the Future Foresight Centre, the study examined initiatives across…
-
BC health research pursues precision, genetics-based care for three conditions
Genome BC-funded projects cover off-the-shelf pharmacogenetic testing, genetically-informed nutrition planning, and predicting therapies for blood cancers. Source: BC health research pursues precision, genetics-based care for three conditions
-
Cellebrite Genesis for Enterprise Now Generally Available, Regional Availability Expands to More Global Markets
TYSONS CORNER, Va. and PETAH TIKVA, Israel, Aug. 19, 2026 /PRNewswire/ — Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the public and private sectors, today announced that Cellebrite Genesis is expanding to more global markets and is now generally available for enterprise organizations. The expansion builds…
-
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026 Source: Vivoryon Therapeutics N.V. to Hold its 2026 Annual General Meeting on September 29, 2026
-
GenScript Reports 27.3% First-Half 2026 Revenue Growth as AI Drug Discovery Business Doubles
Adjusted net profit surges 203.3% as Gene-to-Protein generates two-thirds of GenScript Life Science Group revenue PISCATAWAY, N.J., Aug. 18, 2026 /PRNewswire/ — GenScript Biotech Corporation (HKEX: 1548) reported first-half revenue of approximately US$404.2 million on a comparable basis, up 27.3% year over year, while adjusted net profit rose 203.3% to approximately US$62.5 million. The results…
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
